Sac-TMT significantly extended overall and progression-free survival for patients with advanced or recurrent endometrial ...
The Company will initiate its planned clinical study of BIO 300 Injectable Suspension, subject to Institutional Review Board ...
MustGrow recently announced the receipt of its first development milestone payment Bayer, part of their License and ...
October 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results